tiprankstipranks
Outlook Therapeutics (OTLK)
NASDAQ:OTLK

Outlook Therapeutics (OTLK) Financial Statements

1,120 Followers

Outlook Therapeutics Financial Overview

Outlook Therapeutics's market cap is currently ―. The company's EPS TTM is $-11.475; its P/E ratio is -0.62; Outlook Therapeutics is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is $-1.03. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -68.59M$ -10.32M$ -13.30M$ -21.07M$ -6.65M
EBITDA$ -68.59M$ -10.29M$ -13.29M$ -21.06M$ -6.64M
Net Income Common Stockholders$ -114.29M$ -11.18M$ -12.99M$ -20.68M$ -6.65M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 47.23M$ 10.36M$ 23.39M$ 33.71M$ 43.63M
Total Assets$ 59.03M$ 21.68M$ 32.30M$ 44.45M$ 54.02M
Total Debt$ 44.74M$ 36.55M$ 35.56M$ 34.74M$ 31.84M
Net Debt$ -2.48M$ 26.19M$ 12.16M$ 1.03M$ -11.79M
Total Liabilities$ 193.26M$ 46.03M$ 46.74M$ 49.93M$ 43.53M
Stockholders Equity$ -134.24M$ -24.34M$ -14.44M$ -5.48M$ 10.50M
Cash Flow-
Free Cash Flow-$ -13.03M$ -12.74M$ -13.22M$ -8.11M
Operating Cash Flow$ -19.27M$ -13.03M$ -12.74M$ -13.22M$ -8.11M
Investing Cash Flow-----
Financing Cash Flow$ 56.14M$ -3.18K$ 2.42M$ 3.30M$ -597.13K
Currency in USD

Outlook Therapeutics Earnings and Revenue History

Outlook Therapeutics Debt to Assets

Outlook Therapeutics Cash Flow

Outlook Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis